Coverage
-
June 29, 2020
Fortress, the company that bought blood-testing patents developed by now-defunct Theranos, has dropped an infringement suit against a French biotech outfit working on a COVID-19 test, saying it wants "to allow the defendants to focus their resources on combating the coronavirus."
1 other articles on this case.
View all »